Frohlich Ed

1.0k total citations
30 papers, 616 citations indexed

About

Frohlich Ed is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Frohlich Ed has authored 30 papers receiving a total of 616 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 4 papers in Pulmonary and Respiratory Medicine and 2 papers in Molecular Biology. Recurrent topics in Frohlich Ed's work include Cardiac, Anesthesia and Surgical Outcomes (2 papers), Nitric Oxide and Endothelin Effects (2 papers) and Renal function and acid-base balance (2 papers). Frohlich Ed is often cited by papers focused on Cardiac, Anesthesia and Surgical Outcomes (2 papers), Nitric Oxide and Endothelin Effects (2 papers) and Renal function and acid-base balance (2 papers). Frohlich Ed collaborates with scholars based in United States. Frohlich Ed's co-authors include Tarazi Rc, Pfeffer Ma, Dustan Hp, Solomon Papper, Page Ih, Isaac Kobrin, Gillenwater Jy and Haddy Fj and has published in prestigious journals such as Journal of Clinical Hypertension, PubMed and Munich Personal RePEc Archive (Ludwig Maximilian University of Munich).

In The Last Decade

Frohlich Ed

29 papers receiving 525 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frohlich Ed United States	11	410	115	84	65	64	30	616
Tarazi Rc Italy	11	373 0.9×	82 0.7×	120 1.4×	45 0.7×	77 1.2×	20	521
M A Saragoça Brazil	14	345 0.8×	66 0.6×	114 1.4×	98 1.5×	102 1.6×	34	589
M. B. Kardon United States	14	333 0.8×	55 0.5×	69 0.8×	58 0.9×	71 1.1×	23	476
S Julius United States	13	463 1.1×	57 0.5×	86 1.0×	36 0.6×	77 1.2×	29	588
Wilhelm Raab United States	11	255 0.6×	72 0.6×	47 0.6×	62 1.0×	46 0.7×	13	501
Richard H. Lyons United States	10	273 0.7×	76 0.7×	49 0.6×	38 0.6×	82 1.3×	24	506
Barbara A. Osikowska United Kingdom	9	418 1.0×	74 0.6×	57 0.7×	53 0.8×	123 1.9×	11	587
Linda Kerwin United States	11	682 1.7×	116 1.0×	127 1.5×	151 2.3×	86 1.3×	16	918
D Clement Belgium	13	288 0.7×	75 0.7×	67 0.8×	46 0.7×	80 1.3×	28	418
Halvar Bergman Sweden	9	153 0.4×	149 1.3×	52 0.6×	65 1.0×	47 0.7×	10	432

Countries citing papers authored by Frohlich Ed

Since Specialization

Citations

This map shows the geographic impact of Frohlich Ed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frohlich Ed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frohlich Ed more than expected).

Fields of papers citing papers by Frohlich Ed

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frohlich Ed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frohlich Ed. The network helps show where Frohlich Ed may publish in the future.

Co-authorship network of co-authors of Frohlich Ed

This figure shows the co-authorship network connecting the top 25 collaborators of Frohlich Ed. A scholar is included among the top collaborators of Frohlich Ed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frohlich Ed. Frohlich Ed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ed, Frohlich, et al.. (1992). Quinaprilat increases total body vascular compliance in rats with myocardial infarction.. PubMed. 105(5). 382–9. 1 indexed citations

Ed, Frohlich. (1990). Effect of antihypertensive therapy on left ventricular hypertrophy in essential hypertension.. PubMed. 19. 87–100. 2 indexed citations

Ed, Frohlich. (1990). Left ventricular hypertrophy: an independent factor of risk.. PubMed. 20(3). 85–94. 14 indexed citations

Rc, Tarazi & Frohlich Ed. (1987). Is reversal of cardiac hypertrophy a desirable goal of antihypertensive therapy?. PubMed. 75(1 Pt 2). I113–7. 53 indexed citations

Ed, Frohlich. (1987). Initial therapy for hypertension.. PubMed. 22(5). 89–96. 5 indexed citations

Ed, Frohlich. (1986). Is the spontaneously hypertensive rat a model for human hypertension?. PubMed. 4(3). S15–9. 39 indexed citations

Ed, Frohlich, et al.. (1982). Pathogenesis and pathophysiology of essential hypertension.. PubMed. 71(7). 260–4.

Ed, Frohlich. (1982). Hemodynamic factors in the pathogenesis and maintenance of hypertension.. PubMed. 41(8). 2400–8. 44 indexed citations

Ed, Frohlich. (1978). Essential hypertension: hemodynamics, pressor mechanisms, and mechanisms of drug action.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 9(1). 197–211. 2 indexed citations

10.

Ed, Frohlich, et al.. (1978). Radioenzymatic procedure for urinary oxalate determination.. PubMed. 91(5). 822–30. 12 indexed citations

11.

Ed, Frohlich. (1977). Hemodynamics of hypertension and of hypertensive heart disease.. PubMed. 47(3). 329–35. 1 indexed citations

12.

Ma, Pfeffer, et al.. (1977). Development of a hypertensive strain of Wistar rats from previously normotensive but labile normals.. PubMed. 89(6). 1163–7. 2 indexed citations

13.

Ed, Frohlich, et al.. (1976). Why hypertension is so prevalent in the elderly-and how to treat it.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 31(10). 101–4,108. 5 indexed citations

14.

Ed, Frohlich, et al.. (1976). Comparison of the antihypertensive effectiveness of guanadrel and guanethidine.. PubMed. 19(3). 379–85. 8 indexed citations

15.

Ma, Pfeffer & Frohlich Ed. (1973). Hemodynamic and myocardial function in young and old normotensive and spontaneously hypertensive rats.. PubMed. 32. Suppl 1:28–38. 114 indexed citations

16.

Ed, Frohlich, et al.. (1970). Physiological comparison of labile and essential hypertension.. PubMed. 27(1 Suppl 1). 55–69. 164 indexed citations

17.

Ed, Frohlich. (1966). Prolonged local and systemic hemodynamic effects of hyperosmotic solutions.. PubMed. 161(1). 154–66. 3 indexed citations

18.

Ed, Frohlich, et al.. (1964). DIRECT EFFECTS OF VASOACTIVE AGENTS ON SEGMENTAL RESISTANCE OF THE MESENTERIC AND PORTAL CIRCULATION. STUDIES WITH 1-EPINEPHRINE, LEVARTERENOL, ANGIOTENSIN, VASOPRESSIN, ACETYLCHOLINE, METHACHOLINE, HISTAMINE, AND SEROTONIN.. PubMed. 64. 624–33. 53 indexed citations

19.

Jy, Gillenwater, et al.. (1962). Effect of Salmonella typhosa endotoxin on renal function, and the relationship of function to renal hemodynamics.. PubMed. 20p–20p. 1 indexed citations

20.

Ed, Frohlich, et al.. (1961). Effect of sodium, potassium, calcium, and magnesium upon the resistance to blood flow through the coronary vascular bed of the dog.. PubMed. 477. 1–12. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact